(Q31066773)

28 June 2017

Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis (English)

1 reference

28 June 2017

0 references

Todd A Hardy

1

1 reference

28 June 2017

W Oliver Tobin

series ordinal

2

1 reference

28 June 2017

Claudia F Lucchinetti

series ordinal

3

1 reference

28 June 2017

1 April 2016

1 reference

Multiple Sclerosis Journal

28 June 2017

1 reference

28 June 2017

22

1 reference

28 June 2017

8

1 reference

28 June 2017

986-992

1 reference

Baló's concentric sclerosis

28 June 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Tumefactive demyelination: an approach to diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Pathology of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

The epidemiology of multiple sclerosis: insights to disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Balò's concentric sclerosis presenting with benign clinical course and multiple sclerosis-like lesions on magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Astrocytopathy in Balo's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Vanishing Balò-like lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

The nature of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Balo's concentric sclerosis: new observations on lesion development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Pathologic heterogeneity persists in early active multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Anti-aquaporin-4 antibody-seronegative NMO spectrum disorder with Baló's concentric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

"Clues on Balo's concentric sclerosis evolution from serial analysis of ADC values".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Baló's concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Neuromyelitis optica and concentric rings of Baló in the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

Relapsing-remitting tumefactive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516641776

21 January 2018

Identifiers

DOI

10.1177/1352458516641776

1 reference

release_5wmrlnihnnbi7eu2xflez5swli

28 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5wmrlnihnnbi7eu2xflez5swli

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference